LRCH3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.342950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.587800E-01
Normal-vs-Stage2
1.405390E-01
Normal-vs-Stage3
7.338300E-02
Normal-vs-Stage4
7.112400E-01
Stage1-vs-Stage2
5.509000E-01
Stage1-vs-Stage3
8.235700E-02
Stage1-vs-Stage4
8.569800E-01
Stage2-vs-Stage3
1.270040E-01
Stage2-vs-Stage4
4.380000E-01
Stage3-vs-Stage4
2.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.319560E-01
Normal-vs-AfricanAmerican
4.630600E-01
Normal-vs-Asian
8.069600E-02
Caucasian-vs-AfricanAmerican
6.204400E-01
Caucasian-vs-Asian
1.480850E-01
AfricanAmerican-vs-Asian
2.375000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.269820E-01
Normal-vs-Female
1.648960E-01
Male-vs-Female
5.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.231800E-01
Normal-vs-Age(41-60Yrs)
4.193400E-01
Normal-vs-Age(61-80Yrs)
6.977800E-02
Normal-vs-Age(81-100Yrs)
8.377500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.696800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.900400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.158200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.769200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.741700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.989200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.851700E-02
Normal-vs-Daily Drinker
2.255700E-02
Normal-vs-Weekly Drinker
1.050840E-01
Normal-vs-Occasional Drinker
5.842200E-01
Normal-vs-Social Drinker
5.774600E-01
Non Drinker-vs-Daily Drinker
4.542400E-01
Non Drinker-vs-Weekly Drinker
7.630800E-01
Non Drinker-vs-Occasional Drinker
1.908420E-02
Non Drinker-vs-Social Drinker
2.710200E-02
Daily Drinker-vs-Weekly Drinker
3.293200E-01
Daily Drinker-vs-Occasional Drinker
3.998300E-03
Daily Drinker-vs-Social Drinker
5.743400E-03
Weekly Drinker-vs-Occasional Drinker
8.116100E-02
Weekly Drinker-vs-Social Drinker
9.350000E-02
Occasional Drinker-vs-Social Drinker
9.778200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.066000E-01
Normal-vs-Grade 2
3.317800E-02
Normal-vs-Grade 3
1.827890E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.128440E-01
Grade 1-vs-Grade 3
1.136210E-02
Grade 1-vs-Grade 4
2.066000E-01
Grade 2-vs-Grade 3
6.864100E-02
Grade 2-vs-Grade 4
3.317800E-02
Grade 3-vs-Grade 4
1.827890E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.179800E-02
Normal-vs-NonDiabetic
1.074390E-01
Diabetic-vs-NonDiabetic
5.833400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.552000E-01
Normal-vs-NoPancreatitis
9.886200E-02
Pancreatitis-vs-NoPancreatitis
6.331200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.754620E-01
Normal-vs-N1
1.292050E-01
N0-vs-N1
5.225200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.882800E-01
Normal-vs-TP53-NonMutant
2.338200E-01
TP53-Mutant-vs-TP53-NonMutant
4.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
